{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:44:02Z","timestamp":1791413042436,"version":"4.3.3"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s13181-019-00734-x","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T18:41:47Z","timestamp":1567536107000},"page":"67-70","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Severe Toxicity to the New Psychoactive Substances 3-Hydroxyphencyclidine and N-Ethylhexedrone: an Analytically Confirmed Case Report"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6600-4766","authenticated-orcid":false,"given":"Lisa Christine","family":"Dunlop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Archer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Dargan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,3]]},"reference":[{"issue":"3\u20134","key":"734_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0014-2999(84)90171-7","volume":"101","author":"N Johnson","year":"1984","unstructured":"Johnson N, Itzhak Y, Pasternak GW. Interaction of two phencyclidine opiate-like derivatives with 3H-opioid binding sites. Eur J Pharmacol. 1984;101(3\u20134):281\u20134.","journal-title":"Eur J Pharmacol"},{"issue":"7\u20138","key":"734_CR2","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/dta.1620","volume":"6","author":"H Morris","year":"2014","unstructured":"Morris H, Wallach J. From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs. Drug Test Anal. 2014;6(7\u20138):614\u201332.","journal-title":"Drug Test Anal"},{"issue":"4","key":"734_CR3","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1021\/jm00346a019","volume":"25","author":"JM Kamenka","year":"1982","unstructured":"Kamenka JM, Chiche B, Goudal R, Geneste P, Vignon J, Vincent JP, et al. Chemical synthesis and molecular pharmacology of hydroxylated 1-(1-phenylcyclohexyl-piperidine derivatives). J Med Chem. 1982;25(4):431\u20135.","journal-title":"J Med Chem"},{"issue":"2\u20133","key":"734_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0014-2999(96)00382-2","volume":"310","author":"T Suzuki","year":"1996","unstructured":"Suzuki T, Yamamoto T, Hori T, Baba A, Shiraishi H, Ito T, et al. Autoradiographic study on the pharmacological characteristics of [3H]3-OH-PCP binding sites in rat brain. Eur J Pharmacol. 1996;310(2\u20133):243\u201355.","journal-title":"Eur J Pharmacol"},{"key":"734_CR5","first-page":"173","volume":"75","author":"Y Itzhak","year":"1986","unstructured":"Itzhak Y. High and low affinity psychotomimetic opioid binding sites: characterization by a novel 3H-PCP-analog. NIDA Res Monogr. 1986;75:173\u20136.","journal-title":"NIDA Res Monogr"},{"key":"734_CR6","unstructured":"Blankaert P. FACT SHEET, N-ethylhexedrone Belgium: Belgian Early Warning System Drugs 2016. \nhttps:\/\/erowid.org\/chemicals\/ethylhexedrone\/ethylhexedrone_info1.pdf\n\n. Accessed 08\/02\/2019."},{"issue":"8","key":"734_CR7","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/dta.2136","volume":"9","author":"C Liu","year":"2017","unstructured":"Liu C, Jia W, Li T, Hua Z, Qian Z. Identification and analytical characterization of nine synthetic cathinone derivatives N-ethylhexedrone, 4-Cl-pentedrone, 4-Cl-alpha-EAPP, propylone, N-ethylnorpentylone, 6-MeO-bk-MDMA, alpha-PiHP, 4-Cl-alpha-PHP, and 4-F-alpha-PHP. Drug Test Anal. 2017;9(8):1162\u201371.","journal-title":"Drug Test Anal"},{"key":"734_CR8","doi-asserted-by":"crossref","unstructured":"Eshleman AJ, Nagarajan S, Wolfrum KM, Reed JF, Swanson TL, Nilsen A, et al. Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters. Psychopharmacology. 2018.","DOI":"10.1007\/s00213-018-5059-5"},{"key":"734_CR9","unstructured":"Tripsit. 3-HO-PCP: Tripsit 2019. \nhttp:\/\/drugs.tripsit.me\/3-ho-pcp#summary.\n\n Accessed 08\/02\/2019."},{"issue":"1","key":"734_CR10","first-page":"9","volume":"8","author":"T Bey","year":"2007","unstructured":"Bey T, Patel A. Phencyclidine intoxication and adverse effects: a clinical and pharmacological review of an illicit drug. Cal J Emerg Med. 2007;8(1):9\u201314.","journal-title":"Cal J Emerg Med"},{"key":"734_CR11","unstructured":"Laboratory NF. ANALYTICAL REPORT, N-ethylhexedrone (C14H21NO), 2-(ethylamino)-1-phenylhexan-1-one [Analytical Report]. Slovenia: National Forensic Laboratory; 2016 [updated 02\/10\/2016. \nhttps:\/\/www.policija.si\/apps\/nfl_response_web\/0_Analytical_Reports_final\/N-ethylhexedrone-ID-1503-16-report_final.pdf\n\n Accessed 08\/02\/2019."},{"key":"734_CR12","unstructured":"Erowid Experience Vaults, 3-HO-PCP Reports: Erowid 2019. \nhttps:\/\/erowid.org\/experiences\/subs\/exp_3HOPCP.shtml\n\n. Accessed 24\/07\/2019."}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-019-00734-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13181-019-00734-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-019-00734-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T23:16:23Z","timestamp":1599002183000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13181-019-00734-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,3]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["734"],"URL":"https:\/\/doi.org\/10.1007\/s13181-019-00734-x","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,3]]},"assertion":[{"value":"12 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Consent for publication of this case was obtained and provided to the journal in accordance with JMT policy.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}